161 related articles for article (PubMed ID: 26493994)
1. PKM2 promotes stemness of breast cancer cell by through Wnt/β-catenin pathway.
Zhao Z; Song Z; Liao Z; Liu Z; Sun H; Lei B; Chen W; Dang C
Tumour Biol; 2016 Mar; 37(3):4223-34. PubMed ID: 26493994
[TBL] [Abstract][Full Text] [Related]
2. HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.
Zhang Y; Zhang Q; Cao Z; Huang Y; Cheng S; Pang D
Cell Physiol Biochem; 2018; 46(4):1737-1747. PubMed ID: 29698974
[TBL] [Abstract][Full Text] [Related]
3. Secreted pyruvate kinase M2 facilitates cell migration via PI3K/Akt and Wnt/β-catenin pathway in colon cancer cells.
Yang P; Li Z; Wang Y; Zhang L; Wu H; Li Z
Biochem Biophys Res Commun; 2015 Apr; 459(2):327-332. PubMed ID: 25732087
[TBL] [Abstract][Full Text] [Related]
4. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
[TBL] [Abstract][Full Text] [Related]
6. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
[TBL] [Abstract][Full Text] [Related]
7. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
8. CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling.
Peng F; Yang C; Kong Y; Huang X; Chen Y; Zhou Y; Xie X; Liu P
Curr Cancer Drug Targets; 2020; 20(2):156-165. PubMed ID: 31744448
[TBL] [Abstract][Full Text] [Related]
9. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapy.
Williams KE; Bundred NJ; Landberg G; Clarke RB; Farnie G
Stem Cells; 2015 Feb; 33(2):327-41. PubMed ID: 25187396
[TBL] [Abstract][Full Text] [Related]
11. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
13. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
[TBL] [Abstract][Full Text] [Related]
14. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
Cai C; Zhu X
Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
16. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
[TBL] [Abstract][Full Text] [Related]
17. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
Venugopal A; Subramaniam D; Balmaceda J; Roy B; Dixon DA; Umar S; Weir SJ; Anant S
Mol Carcinog; 2016 Nov; 55(11):1503-1516. PubMed ID: 26331352
[TBL] [Abstract][Full Text] [Related]
18. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
19. BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer.
Zhu L; Pan R; Zhou D; Ye G; Tan W
Cancer Manag Res; 2019; 11():2997-3007. PubMed ID: 31114347
[No Abstract] [Full Text] [Related]
20. FOXA2 suppresses PKM2 transcription and affects the Wnt/β-catenin activity to block aerobic glycolysis in thyroid carcinoma.
He Y; Chen W; Yu L; Liu Y; Cheng Y; Li X; Yu G
Clin Exp Pharmacol Physiol; 2023 Jul; 50(7):561-572. PubMed ID: 36946190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
